Carbon monoxide releasing molecules: New insights for anticoagulation strategy in sepsis

Cellular and Molecular Life Sciences

Volumn 66, Issue 3, 2009, Pages 365-369

  Sun, B W ^a   Chen, X ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Carbon monoxide; Coagulation; Inflammatory response; Sepsis; Strategy

Indexed keywords

ACTIVATED PROTEIN C; CARBON MONOXIDE RELEASING MOLECULE; CARBONYL DERIVATIVE; CELL ADHESION MOLECULE; CYTOKINE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CELL DEATH; CELL PROTECTION; CYTOKINE RELEASE; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR MEMBRANE; LEUKOCYTE; LIPID PEROXIDATION; LUNG LAVAGE; MACROPHAGE; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SEPSIS; SERUM; SHORT SURVEY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMAL INJURY; TISSUE HOMOGENATE; UMBILICAL VEIN;

ANTICOAGULANTS; BLOOD COAGULATION; CARBON MONOXIDE; CELL ADHESION MOLECULES; CYTOKINES; HUMANS; NF-KAPPA B; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; SEPSIS;

EID: 59349117308     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8487-2     Document Type: Short Survey

References (39)

1. Wenzel, R. P. (2002) Treating sepsis. N. Eng. J. Med. 347, 966-967.
2. Wyble, C. W., Desai, T. R., Clark, E. T., Hynes, K. L., Gewertz, B. L. (1996) Physiologic concentrations of TNFa and IL-1b released from reperfused human intestine upregulate E-Selectin and ICAM-1. J. Surg. Res. 63, 333-338.
3. Kuwabara, Y., Kato, T., Sato, A., Fujii, Y. (2000) Prolonged Effect of Leukocytosis on Reperfusion Injury of Rat Intestine: Real-Time ATP Change Studied Using 31P MRS. J. Surg. Res. 89, 38-42.
4. Slofstra, S. H., Veer, C., Buurman, W. A., Reitsma, P. H., ten Cate, H., Spek, C. A. (2005) Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit. Care Med. 33, 1365-1370.
5. Wesche, D. E., Lomas-Neira, J., Perl, M., Chung, C. S., Ayala, A. (2005) Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol. 78, 325-337.
6. Szabo, G., Romics, L., Frendl, G.. (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6, 1045-1066.
7. Esmon, C. T. (2005) The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417-430.
8. Gorman, D., Drewry, A., Huang, Y. L., Sames, C. (2003) The clinical toxicology of carbon monoxide. Toxicology. 187, 25-38.
9. Piantadosi, C. A. (2002) Biological chemistry of carbon monoxide. Antioxid. Redox. Signal. 4, 259-270.
10. Lee, T., Chau, L. Y. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246.
11. Otterbein, L. E., Soares, M., Yamashita, K., Bach, F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455.
12. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Lu, H. T., Wysk, M., Davis, R. J., Flavell, R. A., Choi, A. M. K. (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428.
13. Motterlini, R., Mann, B. E., Johnson, T. R., Clark, J. E., Foresti, R., Green, C. J. (2003) Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr. Pharm. Des. 9, 2525-2539.
14. Motterlini, R., Sawle, P., Hammad, J., Bains, S., Alberto, R., Foresti, R., and Green, C. J. (2005) CORM-A1: a new pharmacologically active carbon monoxidereleasing molecule. FASEB J. 19, 284-286.
15. Motterlini, R., Sawle, P., Hammad, J., Bains, S., Alberto, R., Foresti, R., Green, C. J. (2005) CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J. 19, 284-286.
16. Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., Motterlini, R. (2003) Metal carbonyls: a new class of pharmaceuticals? Angew. Chem. Int. Ed. Engl. 42 ,3722-3729.
17. Sun, B. W., Chen, Z. Y., Chen, X., Liu, C. (2007) Attenuation of Leukocytes Sequestration by CO-releasing Molecules -liberated CO in the Liver of Thermal Mice. J. Burn Care Res. 28, 173-181.
18. Sun, B. W., Sun, H., Liu, C., Shen, J., Chen, Z. Y., Chen, X. (2007) Role of CO-releasing molecules (CORM-2)-liberated CO in attenuating leukocytes sequestration and inflammatory responses in the lung of thermally injured mice. J. Surg. Res. 139, 128-135.
19. Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., Motterlini, R. (2005) Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Bri. J. Pharma 145, 800-810.
20. Willy, C., Dahouk, S., Starck, C., Kaffenberger, W., Gerngross, H., Plappert, U. G.. (2000) DNA damage in humane leucocytes after ischemia/reperfusion injury. Free Rad. Biol. Med. 28, 1-12.
21. Cetinkale, O., Senel, O., Bulan, R. (1999) The effect of antioxidant therapy on cell mediated immunity following burn injury an animal model. Burns 25, 113-118.
22. Sun, B. W., Zou, X. Q., Chen, Y. L., Zhang, P., Shi, G. S. (2008) Preconditioning of Carbon Monoxide Releasing Molecule-derived CO Attenuates LPS-induced Activation of HUVEC. Int. J. Bio. Sci. 4, 270-278.
23. Otterbein, L. E., Alam, J. and Choi, A. M. K. (1998) Gene transfer of heme oxygenase-1 protects rats against hyperoxia. Am. J. Respir. Crit. Care Med. 157, A56.
24. Lee, P. J., Alam, Wiegand, J. G. W. and Choi, A. M. K. (1996) Overexpression of heme oygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA 93, 10393-10398.
25. Hansbrough, J. F., Wikstrom, T., Braide, M., Tenenhaus, M., Rennekampff, O. H., Kiessig, V., Bjursten, L. M. (1996) Neutrophil activation and tissue neutrophil sequestration in a rat model of thermal injury. J. Surg. Res. 61, 17-22.
26. Van der Poll, T., and van Deventer, S. J. (1999) Cytokinces and anticytokinces in the pathogenesis of sepsis. Infect. Dis. Clin. N. Am. 13, 413-426.
27. Morse, D., Pischke, S. E., Zhou, Z., Davis, R. J. (2003) Suppression of Inflammatory Cytokine Production by Carbon Monoxide Involves the JNK Pathway and AP-1. J. Biol. Chem. 278, 36993-36998.
28. Sun, B. W., Sun, Z. W., Jin, Q., Chen, X. (2008) CO-releasing molecules (CORM-2)-liberated CO attenuates infiltration of leukocytes in the renal tissue of thermally injured mice. International J. Biological Sci. 4, 176-183.
29. Sun, B. W., Jin, Q., Sun, Y., Sun, Z. W., Chen, X., Chen, Z. Y., Cepinskas G.. (2007) CO liberated from CO-releasing molecules attenuates leukocytes infiltration in the small intestine of thermally injured mice. World J. Gastroenterol. 13(43), 6183-6190.
30. Deveci, M., Eski, M., Sengezer, M., Kisa, U. (2000) Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF-a levels in burned rats. Burns 26, 41-45.
31. Joseph, C., David, G., Iris, G.. (2003) Modulation of ndotoxin-induced endothelial activity by microtubule depolymerization. J. Trauma 54, 104-113.
32. Jersmann, H. P., Hii, C. S., Ferrante, J. V., Ferrante, A. (2001) Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun. 69, 1273-1279.
33. Martin, G. S., Mannino, D. M., Eaton, S., Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554.
34. Levi, M., ten Cate, H. Disseminated intravascular coagulation. N. Engl. J. Med. 1999; 341:586.
35. Levi, M., Keller, T. T., van Gorp, E., ten Cate, H. (2003) Infection and inflammation and the coagulation system. Cardiovasc. Res. 60, 26-39.
36. Pu, Q., Wiel, E., Corseaux, D., Bordet, R., Azrin, M. A., Ezekowitz, M. D., Lund, N., Jude, B., Vallet, B. (2001) Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock. Crit. Care Med. 29, 1181-1188.
37. Esmon, C. T., Taylor, F. B., Hinshaw, L. B., Chang, A., Comp, P. C., Ferrell, G., Esmon, N. L. (1987) Protein C, isolation and potential use in prevention of thrombosis. Dev. Biol. Stand 67, 51-57.
38. Remick, D. G. (2007) Pathophysiology of Sepsis. Am. J. of Pathol. 170, 1435-1440.
39. Abraham, E., Laterre, P. F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, A., Rossaint, R., Perrotin, D., Sablotzki, A., Arkins, N., Utterback, B. G., Macias, W. L. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 353, 1332-1341.